New: Extracorporeal Hyperthermia Perfusion – EHP^®

EHP^® – Worldwide new and unique multimodal hyperthermia procedure

The Extracorporeal Hyperthermia Perfusion – EHP^® combines for the first time globally process elements of hemoperfusion, hyperthermia, oxygenation and apheresis to a self-contained therapy that is used for cancers, Lyme disease, its CO-infections, numerous chronic diseases, autoimmune diseases or even massive heavy metal pollution and from it resulting diseases. With the EHP^® it is possible to treat these and other diseases effectively and at the same time with minimal side effects.

The EHP^® consists of the following components:

1. Hemo-hyperthermia

Unlike the hyperthermia methods used to date, hemo-hyperthermia does not warm the body from the outside, but rather warms the blood itself to 40 °C to 42.0 °C and sends it into the body.

As a result, in cancer therapy it is possible to direct cytostatics in much higher concentrations than in conventional chemotherapies even directly into the affected target organs and at the same time remove the excess of cytostatics at the end of treatment with a special technique from the organism. This results in fewer side effects with improved effectiveness of the cytostatics.

2. Hemoperfusion

Hemoperfusion is a procedure that eliminates inflammatory and other harmful molecules from the blood of the human organism. In this way we can regulate the metabolism, strengthen the immune system and numerous medicament strategies can be more effective.

Here we work with different techniques that can, for example, discharge heavy metal contamination in just one single treatment. The heavy metals are previously channeled from the tissue into the blood by chelate-builder infusions, with the heat maximizing this process. The heavy metals are then filtered out.

Our form of hemoperfusion is suitable for eliminating sepsis cases (blood poisoning), severe inflammation, cytokines and various toxins. We also use it for the treatment of Lyme disease, autoimmune diseases, cancer, at risk of multiple organ failure, liver disease, kidney disease, systemic inflammatory response syndrome (SIRS – English: systemic inflammatory response syndrome) and lung diseases such as ARDS (ARDS – English: acute respiratory distress syndrome) and much more of the blood. The effectiveness increases thereby maximally.

3. Hyperoxygenated Hemoperfusion

With the use of an oxygenator, the hemoperfusion is extended by one component. This technology comes from cardiac surgery but is also used today in other therapeutic disciplines. The supply of medical oxygen makes it possible to achieve a physical oxygen saturation of more than 700% in the tissue as well. This allows the body’s own repair and regeneration processes to be restarted. In addition, the neovascularization is stimulated and toxins can be better discharged from the organism.

With the EHP, it is now possible for a temperature of up to 42.0 °C in the bloodstream over more than 3 hours to maintain constant in the body. This makes it possible to treat the aforementioned indications – and many others more highly effective at low load for the patient.

We use the EHP^® successfully for the following indications:

• Autoimmune diseases (such as multiple sclerosis, Crohn’s disease, ulcerative colitis, Hashimoto’s thyroiditis and many others)
• Lyme disease
• Cancer
• Liver disease
• Lung disease (ARDS)
• Kidney disease
• Sepsis
• Suspected multiple organ failure
• Heavy metal pollution
• Rheumatic disorders (arthritis, arthrosis, gout etc.)

Do you have questions, or would you like more information about the new EHP^®? Then write us or call us.
Our employees will answer your request quickly and competently. We also call you back by phone to give you individual advice.